Gene...YMB

Dr Marks, FDA has stated that the approval will come between the dates of 9/28- 10/11/2023.

Do not worry everything will be okay. NVAX has Emergency Use Authorization which involves more paperwork.

SK Bio is undergoing the process of contract manufacturing to commercial production.

$400 million to EU, $450 million to Canada, $120 million to Australia already,

$350 million in grants = $1.32 Billion.

The South Korea market could be easily $100 to $200 million revenues in 2023.

So without US sales then NVAX will have $1.42 billion of Revenue which will meet guidance.

I strongly believe that Takeda will work with NVAX to produce a XBB 1.5 variant vaccine.

CVS, Walgreens, and Rite Aid have signed up to carry NVAX.

I have already calculated that when you total up the number of
CVS + Walgreens = 18,441 locations
X 170 doses per store = 3,129,870 doses for only CVS + Walgreens
x $130 per dose = $406,883,100 sales for the US alone.

Dr Marks, FDA has stated that the approval will come between the dates of 9/28- 10/11/2023.

Do not worry everything will be okay. NVAX has Emergency Use Authorization which involves more paperwork.